Agenda - 2025

6th Annual Immuno-Oncology Symposium

Wednesday, May 7, 2025 - 8:30 am to 16:00pm EST

8:30 - 9:00    Sign In & Networking
9:00 - 9:05   Welcome and Opening Remarks - Saman Maleki PhD. and John Ronald PhD. - Conference Co-Chairs      

9:05 - 11:30  SESSION #1

9:05-09:45   Unleashing the anti-tumor potential of B cells and tertiary lymphoid structures for improved therapeutics in cancer patients. - Tullia C. Bruno PhD.

9:45-10:25 Unlocking anti-tumor immunity via modulation of CD8⁺ T cell and the tumor microenvironment. - Hakimeh Ebrahimi-Nik DVM. PhD.

10:25-10:55   Trainee Talks

A - Spatial and Molecular Dissection of Immune-Modulated Niches in Breast Cancer Brain Metastases. Rober Abdo PhD Candidate
B - Single cell characterization of head and neck cancer reveals association of T cell exhaustion and cytotoxicity with disease recurrence and chemoradiation exposure. Shengjie Ying MD/PhD Candidate

 
10:55 - 11:30  Health Break

11:30 - 14:45  SESSION #2

11:30-12:10   Measuring, Modifying and Measuring Modified Microbiomes in the Context of Cancer Immunotherapy. - Bryan Coburn MD. PhD.

12:10-12:50  Dietary deficiency in soluble fibre and host genetics dictate the oncogenic potential of pks+ E. coli in colon carcinogenesis. - Alberto Martin PhD.

12:50-13:20   Trainee Talks

C - Improved Survival in Advanced Melanoma Patients Treated with FecalMicrobiota Transplantation using LND101 in Combination with Anti-PD1: Final Results of the MIMic Phase 1 Safety Trial. Danial Hadi Medical Oncology Fellow
D - Macrophages as regulators of immunotherapy response in immune-hot DNA mismatch repair-deficient tumours. Megan Hong PhD Candidate

13:20 - 14:45  Lunch Break

14:10 - 14:45  Poster Session

14:45 - 16:00  SESSION #3

14:45-15:05  RLT (PRRT) for NETs: Past, Present and Future - David Laidley MD.

15:05-15:25 Prostate Theranostics: Where We Stand and Our Future Directions. - Mina Swiha MD.

15:20-15:55  Trainee Talks

E - Non-Invasive Tracking of SynNotch-Engineered NK-92 Cells Targeting a Novel Ovarian Cancer-Specific Antigen. Alexa Smith MSc. Candidate
F - Disassembly-Reassembly - A New Methodology for Radiolabeling Monoclonal Antibodies. Ruixuan (Nick) Xue MSc. Candidate
16:00  Closing Remarks, Award Presentations & Networking
Saman Maleki PhD. and John Ronald PhD. - Conference Co-Chairs